Yonghu D. Sun

27397 Jingshi Road
Jinan, 250022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 95 publications

Trends in severe cutaneous adverse drug reactions before, during, and after the COVID-19 pandemic: A retrospective multicenter study of 794 cases.

Trends in severe cutaneous adverse drug reactions before, during, and after the COVID-19 pandemic: A retrospective multicenter study of 794 cases.

Journal: JAAD international

Published: August 09, 2026

Combination of concentrated growth factor and collagen filler for recalcitrant atrophic scars: Two case reports.

Combination of concentrated growth factor and collagen filler for recalcitrant atrophic scars: Two case reports.

Journal: JAAD case reports

Published: July 19, 2026

New insights into the diagnosis and management of patients with cutaneous drug hypersensitivity.

New insights into the diagnosis and management of patients with cutaneous drug hypersensitivity.

Journal: Current opinion in allergy and clinical immunology

Published: June 03, 2026

Proteomic Profiling Reveals a Cytokine-Chemokine Axis Involving CXCL10, CD40, and CCL17 in Dermatitis Herpetiformis Pathogenesis and Treatment Response.

Proteomic Profiling Reveals a Cytokine-Chemokine Axis Involving CXCL10, CD40, and CCL17 in Dermatitis Herpetiformis Pathogenesis and Treatment Response.

Journal: The British journal of dermatology

Published: May 07, 2026

Omeprazole activation of CD4+ and CD8+ T-cells through off-target covalent modification of cellular proteins.

Omeprazole activation of CD4+ and CD8+ T-cells through off-target covalent modification of cellular proteins.

Journal: Toxicological sciences : an official journal of the Society of Toxicology

Published: April 27, 2026

TNF-alpha is a master regulator of drug-specific T-cell activation.

TNF-alpha is a master regulator of drug-specific T-cell activation.

Journal: The Journal of allergy and clinical immunology

Published: March 27, 2026

Two cases of high risk childhood acute myeloid leukemia with positive FUS/TLS∷ERG treated with cladribine-based chemotherapy

Two cases of high risk childhood acute myeloid leukemia with positive FUS/TLS∷ERG treated with cladribine-based chemotherapy

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics

Published: October 14, 2025

Treatment of juvenile localized scleroderma with upadacitinib: A case series.

Treatment of juvenile localized scleroderma with upadacitinib: A case series.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: October 14, 2025

Artificial intelligence-driven comparative efficacy of topical crisaborole versus halometasone for vitiligo: A randomized and noninferiority study.

Artificial intelligence-driven comparative efficacy of topical crisaborole versus halometasone for vitiligo: A randomized and noninferiority study.

Journal: Journal of the American Academy of Dermatology

Published: September 04, 2025

Dermatology images: Orf.

Dermatology images: Orf.

Journal: Journal of the American Academy of Dermatology

Published: September 01, 2025

Dual Blocking of IL17A and IL36R for the Treatment of Refractory Hidradenitis Suppurativa: A Case Report.

Dual Blocking of IL17A and IL36R for the Treatment of Refractory Hidradenitis Suppurativa: A Case Report.

Journal: Biologics : targets & therapy

Published: August 13, 2025

Upadacitinib for Treatment of Hyper-IgE Syndrome.

Upadacitinib for Treatment of Hyper-IgE Syndrome.

Journal: JAMA dermatology

Published: August 06, 2025

Showing 1-12 of 95

Last Updated: 09/26/2026